Bio Green Med Solution, Inc.
BGMS
$0.86
-$0.02-2.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 18,510.00% | 10,792.86% | 1,637.21% | 9.46% | -87.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18,510.00% | 10,792.86% | 1,637.21% | 9.46% | -87.50% |
| Cost of Revenue | -17.04% | -67.38% | -84.04% | -85.45% | -82.88% |
| Gross Profit | 120.08% | 107.43% | 103.69% | 86.57% | 82.85% |
| SG&A Expenses | -58.94% | -51.50% | 42.62% | 17.03% | 13.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.48% | -57.11% | -31.24% | -46.42% | -53.27% |
| Operating Income | 71.08% | 69.91% | 37.21% | 46.69% | 53.14% |
| Income Before Tax | 77.24% | 74.71% | 41.24% | 47.56% | 53.45% |
| Income Tax Expenses | -95.54% | -93.53% | 100.90% | 149.87% | 134.52% |
| Earnings from Continuing Operations | 78.97% | 75.58% | 37.08% | 29.30% | 40.22% |
| Earnings from Discontinued Operations | -- | -101.65% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.65% | 62.69% | 73.26% | 59.50% | 63.40% |
| EBIT | 71.08% | 69.91% | 37.21% | 46.69% | 53.14% |
| EBITDA | 71.12% | 69.95% | 37.23% | 46.66% | 53.11% |
| EPS Basic | 97.08% | 98.46% | 98.40% | 62.14% | 27.83% |
| Normalized Basic EPS | 99.31% | 98.53% | 86.48% | -26.18% | -- |
| EPS Diluted | 97.08% | 98.46% | 98.40% | 62.14% | 27.83% |
| Normalized Diluted EPS | 99.31% | 98.53% | 86.48% | -26.18% | -- |
| Average Basic Shares Outstanding | 871.62% | 2,874.69% | 9,809.98% | 8,125.50% | -- |
| Average Diluted Shares Outstanding | 871.62% | 2,754.38% | 7,975.51% | 5,681.13% | 9,471.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -3.33% | -- | -- | -1.02% | -0.12% |